Non-Accredited Education
Understanding Collagen Dressings and their Benefit in Wound Care Complimentary Archived Webcast
Non-Accredited
Issue
- Issue:2
Over the last 2 millennia, many civilizations have recognized silver as a treatment for preventing diseases.1 Within the last 50 years, following renewed interest in the use of silver nitrate solution for burn wound infections,2 silver became known as one of the least toxic antimicrobial agents and regained widespread acceptance in wound care.3
- Issue:2
Chronic wounds affect many people, causing morbidity, interference with quality of life, hardship for the patient, and economic strain on the healthcare system. In order for chronic wounds to be treated effectively, several conditions must be met. An appropriate diagnosis is critical because treatment of the underlying or associated pathology is important in resolving these ulcers.1,2 Once these basic issues are addressed, the direct management of the ulcer requires a process of wound bed preparation.
- Issue:2
Lipomembranous panniculitis is a fibrotic process that usually occurs in the legs. This condition has also been referred to as lipodermatosclerosis, venous stasis panniculitis, or hypodermitis sclerodermiformis. The principal features are a sclerosing panniculitis with dermal and subcutaneous fibrosis and fat necrosis. Although the exact pathogenesis is uncertain, it is thought to occur as a result of ischemic changes.1
- Issue:2
Swan and Banwell advocate the use of formal topical negative pressure (TNP) abdominal dressing systems for the treatment of open abdomens in cases of exposed bowel, omentum, or intra-abdominal sepsis.1,2 The formal TNP abdominal dressing system (V.A.C.® Therapy™ System, KCI, San Antonio, Tex) consists of a fenestrated nonadherent piece of plastic with encapsulated foam, which is placed between the abdominal organs and the peritoneum of the abdominal wall. On top of this, an additional layer of polyurethane foam is placed.
- Issue:2
Antibiotic Treatment Cubicin® Granted Marketing Approval
Chiron Corporation (Emeryville, Calif) announces that the European Commission has granted marketing approval for Cubicin® (daptomycin), an intravenous (IV) antibiotic. The marketing approval was granted in the 25 member states of the European Union, Iceland, Liechtenstein, and Norway. Cubicin is indicated for the treatment of complicated skin and soft tissue infections (cSSTIs) caused by gram-positive bacteria under the approval.
- Issue:2
3M Launches Tegaderm™ Ag Mesh Dressing with Silver
3M (St. Paul, Minn) announces the launch of 3M Tegaderm™ Ag Mesh Dressing with Silver, a new wound care product with fast-acting, long-lasting antimicrobial barrier effectiveness against a wide range of microbes, including antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE*).
Press Release
ConvaTec and Boehringer Technologies Announce License Agreement
ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System
SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.
WOUNDS News Wire
- Friday, December 5, 2008 - 15:08
- Wednesday, October 22, 2008 - 15:28
- Wednesday, October 22, 2008 - 15:25
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009 Rebroadcasts 7:30-8:30 p.m. EDT 3-4 p.m. EDT This activity is supported by an educational grant from Advanced Biohealing. To register for this Webcast, visit www.naccme.com/program/n-550/ |
| MRSA And Diabetic Foot Wounds: Where Do We Go From Here? Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
|
PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Maintenance Debridement: A New Look at Science and Art Accredited Webcast with Q&A: November 17, 2008 at 3:00pm EST This activity is supported by an educational grant from HealthPoint Ltd. |
REVIEW OUR OTHER
WOUND CARE BRANDS
Check out our other resources for healthcare professionals of all specialties.
